News

The University of Birmingham has made the first investment from its £5m University of Birmingham Spinout Investment fund, to Smart Antenna Technologies, a spinout founded in 2013 to develop a new generation of antenna for smart phones and laptops.

Tamsin Mann, PraxisUnico's Policy Officer, has a look at the year in review.

Oxford Sciences Innovation plc (OSI) , created by The University of Oxford and Isis Innovation, to commercialise academic ideas into market-leading companies, has successfully raised £230m to fund spin-out companies. The funds will provide capital and scaling expertise to companies spun-out of the university.

The Scottish Knowledge Exchange Awards promote and celebrate knowledge exchange in Scotland encouraging more businesses to consider Scotland’s universities and research institutions as a collaborative partner.

PraxisUnico welcomes the Chancellor's significant investment in research and innovation announced in Wednesday's Autumn Statement. We are encouraged that this will allow the investments that HEFCE, RCUK and Innovate UK have made in building the bridges between research and business communities to be extended further, and will allow the UKRI to develop a holistic approach to supporting research and innovation across all of their responsibilities.

This new report from the CBI highlights the importance of relationships between UK universities and the economic opportunities in China, and the amazing impact that UK universities generate from research in the region.

Do you want to turn your science into a life-changing product?

PraxisUnico is delighted to announce the 2017 Training Schedule.

Dr Phil Clare, Chair of PraxisUnico's Advocacy Committee, will be appearing in front of MP's at today's Science & Technology Select Committee hearing.

A consultation process launches today to collect views of the AURIL and PraxisUnico membership on the proposed development of a new organisation.

Part 3 of the PraxisUnico Conference podcasts, Malcolm Skingle and other speakers including Robert Sorrell speaks about "Innovating Exploitation Models"

11 proposals will be brought into effect, as detailed in the response document.

The first of our Conference podcasts is now available, sponsored by Forresters.

Hot off the presses, our conference newsletter.

Mercia Fund Management has followed up on its first investment in 2015 with follow-on capital to Medherant Ltd. A total of £250,000 from both Mercia’s third-party University Growth Fund and Growth Fund 4 will allow Medherant to continue product development. Medherant has moved to new laboratories, and KEC professional Andrew Lee has been seconded from Warwick Ventures to the project.

Dr Emma Elliott RTTP was the successful applicant for the Inteum sponsored scholarship to attend this year's PraxisUnico Conference

Since 2009, Innovation Prize awards the most innovative startups (<8 years old) and the best research academic groups that are developing cutting edge technologies in the field of life sciences (Biotech, Medtech, m/e-health, diagnostics). The Innovation Prize of Universal Biotech aims to promote on an international scale the most innovative projects in the field of Life Sciences. The awarding ceremony will be held at the Innovation Days 2016, a networking BtoB event which will take place at the Maison de la Chimie in Paris, on October the 3rd & the 4th.

Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO, effective from 23 May 2016.

PraxisUnico members can join the Network for the Assessment & Evaluation of the Societal Impact of Science (AESIS) Network free of charge and benefit from additional discounts and services

NCUB have completed a new survey of over 18,000 academics in the UK looking at the changing state of Knowledge Exchange. The report looks at academic interactions with external organisations. The report shows that 30% of academics actively work with private companies, and the bulk of research taking place is user-inspired or applied.

Cancer Research Technology enter into a licence agreement with international pharmaceutical company MSD to develop inhibitors of protein arginine methyltransferase 5 (PRMT5) for cancer and blood dissorder. The new drugs potentially have clinical applications in both cancer and non-cancer blood disorders.

First published on 21st January 2016 the Intellectual Property Office has proudly introduced their five year strategy.

The University of Manchester, PraxisUnico member, and Masdar Institute of Science & Technology, in Abu Dhabi launch collaborative research into graphene and 2D materials to develop desalination, energy and defence applications and various engineering applications.

PraxisUnico highlighted the role of KEC in its submission.

Investments are growing for the researchers at University of Bristol. The 'Enterprise Fund' was launched on 15th January to provide extra support for spin-outs and tax relief for individual investors who are purchase shares in those new companies.

IP Pragmatics, an IP and business development consulting firm, expands its operations in the UK with a new office in Edinburgh.

The Pioneer Award will fund research into truly innovative, ground-breaking ideas with the potential to lead to new discoveries